Evidence map›Paper›PMID 39611407›Full record

ArticlemAbs

Humatch - fast, gene-specific joint humanisation of antibody heavy and light chains.

Lewis Chinery, Jeliazko R Jeliazkov, Charlotte M Deane

Abstract read
In one paragraph

Article in mAbs. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. AI-based antibody design targeting recent H5N1 avian influenza strains.Computational and structural biotechnology journal · 2025
    Article
  8. p-IgGen: a paired antibody generative language model.Bioinformatics (Oxford, England) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lewis ChineryDepartment of Statistics, University of Oxford, Oxford, UK.ORCID 0000-0002-9222-185X
Jeliazko R JeliazkovProtein Design and Informatics, Research Technologies, GSK R&D, Upper Providence, USA.ORCID 0000-0003-4249-1955
Charlotte M DeaneDepartment of Statistics, University of Oxford, Oxford, UK.ORCID 0000-0003-1388-2252

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibodies are a popular and powerful class of therapeutic due to their ability to exhibit high affinity and specificity to target proteins. However, the majority of antibody therapeutics are not genetically human, with initial therapeutic designs typically obtained from animal models. Humanization of these precursors is essential to reduce immunogenic risks when administered to humans.Here, we present Humatch, a computational tool designed to offer experimental-like joint humanization of heavy and light chains in seconds. Humatch consists of three lightweight Convolutional Neural Networks (CNNs) trained to identify human heavy V-genes, light V-genes, and well-paired antibody sequences with near-perfect accuracy. We show that these CNNs, alongside germline similarity, can be used for fast humanization that aligns well with known experimental data. Throughout the humanization process, a sequence is guided toward a specific target gene and away from others via multiclass CNN outputs and gene-specific germline data. This guidance ensures final humanized designs do not sit 'between' genes, a trait that is not naturally observed. Humatch's optimization toward specific genes and good VH/VL pairing increases the chances that final designs will be stable and express well and reduces the chances of immunogenic epitopes forming between the two chains. Humatch's training data and source code are provided open-source.

Indexed as

Immunoglobulin Heavy ChainsImmunoglobulin Light ChainsAnimalsAntibodies, Monoclonal, HumanizedHumansNeural Networks, ComputerSoftwareAntibodies, Monoclonal, HumanizedImmunoglobulin Heavy ChainsImmunoglobulin Light Chainsantibodyhumanisationmachine learningpairedv-gene

Identifiers

PMID39611407
PMCPMC11610552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.